ABAX - Abaxis, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
62.72
+1.56 (+2.55%)
At close: 4:00PM EST

62.72 0.00 (0.00%)
After hours: 4:40PM EST

Stock chart is not supported by your current browser
Previous Close61.16
Open61.56
Bid34.86 x 200
Ask63.00 x 800
Day's Range61.38 - 62.94
52 Week Range43.66 - 63.18
Volume177,485
Avg. Volume149,054
Market Cap1.424B
Beta1.30
PE Ratio (TTM)52.71
EPS (TTM)1.19
Earnings DateJan 25, 2018
Forward Dividend & Yield0.64 (1.05%)
Ex-Dividend Date2017-11-30
1y Target Est52.38
Trade prices are not sourced from all markets
  • PR Newswire13 hours ago

    Abaxis, Inc. Announces USDA Approval of New VetScan FLEX4 Rapid Test

    UNION CITY, Calif., Jan. 22, 2018 /PRNewswire/ -- Abaxis, Inc. (ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets worldwide, today announced that the USDA, Center for Veterinary Biologics, approved its new VetScan FLEX4 Rapid Test for veterinary use. The FLEX4 Rapid Test is the newest addition to the VetScan Rapid Test product family.  The VetScan FLEX4 Rapid Test offers improved shelf-life, ease-of-use, room temperature storage, and price when compared to competing products.

  • PR Newswire5 days ago

    Abaxis To Report Third Quarter Fiscal Year 2018 Financial Results On Thursday, January 25, 2018

    UNION CITY, Calif. , Jan. 17, 2018 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary ...

  • Abaxis' Product Line Expansion Aids Growth, Rivalry Rife
    Zacks10 days ago

    Abaxis' Product Line Expansion Aids Growth, Rivalry Rife

    Abaxis' (ABAX) growing portfolio of rapid test menu and a strong performance in Veterinary consumables drive growth. Intense competition in both the Medical and Veterinary markets is a concern.

  • Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors
    Zacks11 days ago

    Abaxis' (ABAX) Preliminary Results for Q3 Cheer Investors

    Abaxis (ABAX) expects substantial tax savings from the recent U.S. tax reform.

  • PR Newswire14 days ago

    Abaxis Reports Preliminary Financial Performance for the Third Quarter of Fiscal 2018

    UNION CITY, Calif., Jan. 9, 2018 /PRNewswire/ -- Abaxis, Inc. (ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary markets worldwide, today reported preliminary financial results for the third fiscal quarter ended December 31, 2017. Abaxis expects revenues in the third fiscal quarter of fiscal 2018 in a range of $59.0 million to $60.0 million, an increase of 12% to 14%, over last year's comparable quarter.  In addition, Abaxis expects operating income before income tax provision in the third fiscal quarter of fiscal 2018 of $9.0 million to $10.0 million compared to $10.8 million in last year's third quarter.  Abaxis expects its gross margin for the third fiscal quarter of fiscal 2018 to be between 53.5% and 54.0%.

  • PR Newswire20 days ago

    Abaxis, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference

    UNION CITY, Calif. , Jan. 2, 2018 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care instruments and consumables for the medical and veterinary markets ...

  • Capital Cube26 days ago

    ETFs with exposure to ABAXIS, Inc. : December 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABAXIS, Inc. Here are 5 ETFs with the largest exposure to ABAX-US. Comparing the performance and risk of ABAXIS, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Abaxis Well Poised on Solid Prospects, Competition Rife
    Zacks26 days ago

    Abaxis Well Poised on Solid Prospects, Competition Rife

    Abaxis' (ABAX) new sales and marketing strategies boost investors' confidence.

  • New Strong Sell Stocks for December 7th
    Zacks2 months ago

    New Strong Sell Stocks for December 7th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Capital Cube2 months ago

    ETFs with exposure to ABAXIS, Inc. : December 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABAXIS, Inc. Here are 5 ETFs with the largest exposure to ABAX-US. Comparing the performance and risk of ABAXIS, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : December 6, 2017
    Capital Cube2 months ago

    ABAXIS, Inc. breached its 50 day moving average in a Bearish Manner : ABAX-US : December 6, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ABAXIS, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q2, 2018 By the Numbers : December 5, 2017
    Capital Cube2 months ago

    ABAXIS, Inc. :ABAX-US: Earnings Analysis: Q2, 2018 By the Numbers : December 5, 2017

    Categories: Yahoo FinanceGet free summary analysis ABAXIS, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of ABAXIS, Inc. – Becton, Dickinson and Company, IDEXX Laboratories, Inc., Integra LifeSciences Holdings Corporation, West Pharmaceutical Services, Inc., ICU Medical, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Heska Corporation ... Read more (Read more...)

  • ABAXIS, Inc. : ABAX-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 1, 2017
    Capital Cube2 months ago

    ABAXIS, Inc. : ABAX-US: Dividend Analysis : December 01st, 2017 (record date) : By the numbers : December 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Our analysis is based on comparing ABAXIS, Inc. with the following peers – Becton, Dickinson and Company, IDEXX Laboratories, Inc., Integra LifeSciences Holdings Corporation, West Pharmaceutical Services, Inc., ICU Medical, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Heska Corporation and Johnson & Johnson (BDX-US, IDXX-US, IART-US, WST-US, ICUI-US, TMO-US, ABT-US, HSKA-US ... Read more (Read more...)

  • ABAXIS (ABAX) Up 6.7% Since Earnings Report: Can It Continue?
    Zacks2 months ago

    ABAXIS (ABAX) Up 6.7% Since Earnings Report: Can It Continue?

    ABAXIS (ABAX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • PR Newswire2 months ago

    Abaxis, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference

    UNION CITY, Calif. , Nov. 21, 2017 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and ...

  • ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : November 10, 2017
    Capital Cube2 months ago

    ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : November 10, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ABAXIS, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • GlobeNewswire3 months ago

    Report: Developing Opportunities within Abaxis, PRA Health Sciences, Brighthouse, Investors Bancorp, Cypress Semiconductor, and Sage Therapeutics – Future Expectations, Projections Moving into 2018

    NEW YORK, Nov. 06, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Abaxis, ...

  • Capital Cube3 months ago

    ETFs with exposure to ABAXIS, Inc. : October 26, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABAXIS, Inc. Here are 5 ETFs with the largest exposure to ABAX-US. Comparing the performance and risk of ABAXIS, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of ABAX earnings conference call or presentation 24-Oct-17 8:15pm GMT

    Q2 2018 Abaxis Inc Earnings Call

  • Abaxis (ABAX) Posts In-Line Earnings in Q2, Lags Revenues
    Zacks3 months ago

    Abaxis (ABAX) Posts In-Line Earnings in Q2, Lags Revenues

    Abaxis (ABAX) misses the Zacks Consensus Estimate for revenues due to softness in the medical market in Q2. Weak margins are a concern as well.

  • PR Newswire3 months ago

    Abaxis Reports Financial Performance for the Second Quarter of Fiscal 2018 and Declares Quarterly Cash Dividend

    UNION CITY, Calif. , Oct. 24, 2017 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary ...

  • PR Newswire3 months ago

    Abaxis To Report Second Quarter Fiscal Year 2018 Financial Results On Tuesday, October 24, 2017

    UNION CITY, Calif. , Oct. 17, 2017 /PRNewswire/ -- Abaxis, Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing point-of-care blood analysis instruments and consumables for the medical and veterinary ...

  • Capital Cube3 months ago

    ETFs with exposure to ABAXIS, Inc. : October 10, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to ABAXIS, Inc. Here are 5 ETFs with the largest exposure to ABAX-US. Comparing the performance and risk of ABAXIS, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Capital Cube4 months ago

    ABAXIS, Inc. – Value Analysis (NASDAQ:ABAX) : October 6, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives ABAXIS, Inc. a score of 69. Our analysis is based on comparing ABAXIS, Inc. with the following peers – Becton, Dickinson and Company, IDEXX Laboratories, Inc., Integra LifeSciences Holdings Corporation, West Pharmaceutical Services, Inc., ICU Medical, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Heska Corporation and Johnson ... Read more (Read more...)

  • ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : October 5, 2017
    Capital Cube4 months ago

    ABAXIS, Inc. breached its 50 day moving average in a Bullish Manner : ABAX-US : October 5, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for ABAXIS, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)